by John A. Jenkins | Dec 6, 2023 | FOIA, SEC, Short-Selling, Stock Market
Another Short Seller Hits FOIAengine’s Radar It gets our attention when a short seller hits FOIAengine’s radar for the first time. This week, we’re talking about Nathan Koppikar – Nate, for short – and his impactful short-seller fund, Orso Partners. Orso means “bear”...
by John A. Jenkins | Nov 29, 2023 | FOIA, Politics, SEC
FOIAengine Finds SEC Chair in a Harsh Spotlight You’ve probably seen Rep. Patrick McHenry (R-NC), whether you know it or not. For a few weeks last month, he was one of the most recognizable, least known lawmakers on Capitol Hill. Professorial mien. Bow tie. Cool...
by Randy E. Miller | Nov 16, 2023 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
FOIAengine Reveals Threat of Litigation Personal injury law firm Morgan & Morgan is gearing up for what could be extensive litigation against the makers of popular weight control drugs. On October 12, the Orlando, Florida-based law firm submitted to the Food and...
by John A. Jenkins | Nov 2, 2023 | FDA, FOIA, Pharmaceuticals
In FOIAengine, Media Requests Seek the Answer When word leaked in late August that the Department of Health and Human Services recommended that marijuana should no longer be considered a dangerous drug, media organizations quickly responded with a flurry of Freedom of...
by John A. Jenkins | Oct 25, 2023 | FDA, FOIA, Litigation, Pharmaceuticals
In FOIAengine, a Slew of Requests About Ivermectin Robert Califf headed up the Food and Drug Administration during the last year of the Obama Administration. By the time Califf spun through the revolving door, returning to his old job early in 2022, he’d picked up...
by Randy E. Miller | Oct 18, 2023 | Cryptocurrency, FOIA, Politics, SEC
FOIAengine Analysis of SEC Requests Reveals Insights An analysis of Freedom of Information Act requests to the Securities and Exchange Commission over the past six months highlights investor interest in several of the leading storylines of the year, including the...
